Paper. Lu OD, White K, Raymond KB et al.. Nature Neuroscience, 2 Nov 2026.
Tags: Animal, Psilocybin, Depression, Anxiety.
Five independent labs ran the same psilocybin experiments; the next-day effects vanished.
Acute psilocybin (2 mg/kg IP) reliably increased anxiety- and avoidance-related behaviour and reduced fear expression across all sites. At 24 hours there was no replicable reduction in anxiety- or depression-like behaviour, no facilitation of fear extinction, and no change in social preference or social reward learning.
How much weight it carries: Prospective five-site replication with ~200 mice per experiment; strong evidence about rodent assays, silent on human clinical durability. (Mice, Controlled, Preclinical, Peer reviewed)